6 billion units of pills and 90 million units of oral liquids per year. This plant is expected to be completely operational by the end of 2022. Contract manufacturing pharmaceutical firm Akums Drugs & Pharmaceuticals Ltd has purchased a plant from Ankur Drugs and Pharmaceuticals Limited in Himachal Pradesh to expand its manufacturing capacity for general oral tablets and oral liquids.
Sandeep Jain, founder, promoter and director at Akums Drugs & Pharmaceuticals, expressed optimism over the new facility. He said, “With this new facility in Nalagarh in Solan, Himachal Pradesh, we are trying to bridge some more capacity gaps in the pharma industry. What the addition of this new facility means to our existing network is to step up our continuous efforts to serve our customers efficiently and the nation better.”
In addition to these improvements, in January 2022, Akums bought three API facilities near Chandigarh. All of this adds to the company’s capacity development and effective backward-integrated supply chain, which helps the company maintain its market leadership position in India. Akums produces around 12% of all pharmaceuticals taken in the country.
Sanjeev Jain, founder, promoter and director at Akums Drugs & Pharmaceuticals, expressed hopes over the new acquisition. He said, “In 2021, our supplies made up approximately 12% of the total market. With this new facility acquisition in the state of Himachal Pradesh and our previous acquisition in Kotdwar, Uttarakhand, in August 2021, we have bolstered our total capacity further. This expansion is a step towards achieving our goal of 20% market share. The operations at our Kotdwar plant have begun recently, while our new plant in Himachal Pradesh is likely to start its operations by December 2022.”
Akums Drugs & Pharmaceuticals Ltd. is India’s leading contract manufacturing pharmaceutical firm, producing over 12% of the country’s pharmaceutical consumption. The organization produces and exports formulations over a broad range of dosage forms and therapeutic segments. The firm today supplies practically to all Indian and global pharmaceutical industries and is one of the major employers in the country.
The ten advanced facilities are allotted to oral solid dosage forms with different units for beta lactum and non-beta lactum formulations, oral liquid dosage forms, sterile dosage forms (injectable, eye, ear, and nasal), hormonal dosage forms (oral and injectable), ointments and cosmetics, Ayurveda, food supplements and nutraceuticals, and animal healthcare.
